 Inspire Medical Systems Inc NYSE: INSP expects Q4 FY21 revenue of 78.0 million - 78.4 million, up approximately 70 YY and surpassing the consensus estimate of 65.84 million. For FY21, the Company sees sales of 233.0 million - 233.4 million, an approximately 102 increase over FY20. 